Literature DB >> 15843175

Enzymatic profiling of human kallikrein 14 using phage-display substrate technology.

Loyse M Felber1, Carla A Borgoño, Sylvain M Cloutier, Christoph Kündig, Tadaaki Kishi, Jair Ribeiro Chagas, Patrice Jichlinski, Christian M Gygi, Hans-Jürg Leisinger, Eleftherios P Diamandis, David Deperthes.   

Abstract

The human KLK14 gene is one of the newly identified serine protease genes belonging to the human kallikrein family, which contains 15 members. KLK14 , like all other members of the human kallikrein family, is predicted to encode for a secreted serine protease already found in various biological fluids. This new kallikrein is mainly expressed in prostate and endocrine tissues, but its function is still unknown. Recent studies have demonstrated that KLK14 gene expression is up-regulated in prostate and breast cancer tissues, and that higher expression levels correlate with more aggressive tumors. In this work, we used phage-display substrate technology to study the substrate specificity of hK14. A phage-displayed random pentapeptide library with exhaustive diversity was screened with purified recombinant hK14. Highly specific and sensitive substrates were selected from the library. We show that hK14 has dual activity, trypsin- and chymotrypsin-like, with a preference for cleavage after arginine residues. A SwissProt database search with selected sequences identified six potential human protein substrates for hK14. Two of them, laminin alpha-5 and collagen IV, which are major components of the extracellular matrix, have been demonstrated to be hydrolyzed efficiently by hK14.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15843175     DOI: 10.1515/BC.2005.035

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  9 in total

1.  Substrate specificity of human kallikreins 1 and 6 determined by phage display.

Authors:  Hai-Xin Li; Bum-Yeol Hwang; Gurunathan Laxmikanthan; Sachiko I Blaber; Michael Blaber; Pavel A Golubkov; Pengyu Ren; Brent L Iverson; George Georgiou
Journal:  Protein Sci       Date:  2008-04       Impact factor: 6.725

Review 2.  Unleashing the therapeutic potential of human kallikrein-related serine proteases.

Authors:  Ioannis Prassas; Azza Eissa; Gennadiy Poda; Eleftherios P Diamandis
Journal:  Nat Rev Drug Discov       Date:  2015-02-20       Impact factor: 84.694

3.  Novel Biological Substrates of Human Kallikrein 7 Identified through Degradomics.

Authors:  Yijing Yu; Ioannis Prassas; Apostolos Dimitromanolakis; Eleftherios P Diamandis
Journal:  J Biol Chem       Date:  2015-06-01       Impact factor: 5.157

Review 4.  Strategies for Tuning the Selectivity of Chemical Probes that Target Serine Hydrolases.

Authors:  Franco Faucher; John M Bennett; Matthew Bogyo; Scott Lovell
Journal:  Cell Chem Biol       Date:  2020-07-28       Impact factor: 8.116

Review 5.  Proteinases, proteinase-activated receptors (PARs) and the pathophysiology of cancer and diseases of the cardiovascular, musculoskeletal, nervous and gastrointestinal systems.

Authors:  Kristina K Hansen; Katerina Oikonomopoulou; Yang Li; Morley D Hollenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-10-19       Impact factor: 3.000

Review 6.  Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs).

Authors:  Peter Goettig; Viktor Magdolen; Hans Brandstetter
Journal:  Biochimie       Date:  2010-07-06       Impact factor: 4.079

7.  Implantation serine proteinase 1 exhibits mixed substrate specificity that silences signaling via proteinase-activated receptors.

Authors:  Navneet Sharma; Rajeev Kumar; Bernard Renaux; Mahmoud Saifeddine; Sandra Nishikawa; Koichiro Mihara; Rithwik Ramachandran; Morley D Hollenberg; Derrick E Rancourt
Journal:  PLoS One       Date:  2011-11-23       Impact factor: 3.240

8.  Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status.

Authors:  F Fritzsche; T Gansukh; C A Borgoño; M Burkhardt; S Pahl; E Mayordomo; K-J Winzer; W Weichert; C Denkert; K Jung; C Stephan; M Dietel; E P Diamandis; E Dahl; G Kristiansen
Journal:  Br J Cancer       Date:  2006-02-27       Impact factor: 7.640

Review 9.  Emerging challenges in the design of selective substrates, inhibitors and activity-based probes for indistinguishable proteases.

Authors:  Paulina Kasperkiewicz; Marcin Poreba; Katarzyna Groborz; Marcin Drag
Journal:  FEBS J       Date:  2017-01-29       Impact factor: 5.542

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.